Discovering music like never before: Meludia's journey continues for MED-EL users
February 4, 2024 – (Innsbruck, Austria): MED-EL, a global leader in implantable hearing solutions, has announced the continued availability of a complementary 12-month subscription to online music training program Meludia for people with hearing implants, their caregivers, and hearing professionals.
- Free 12-month Meludia subscriptions for all myMED-EL users continues globally
- Now also available in Canada
- New! Russian and Turkish language versions online
- MED-EL and Meludia empower users to enhance listening skills and cognitive abilities through musical brain-training
Immediate access to Meludia's rich musical training universe awaits all myMED-EL account holders as the prolonged collaboration ensures unrestricted access to content that has been specifically optimized for people living with hearing loss.
In 2022, two of the world’s leading experts in hearing loss and brain-training – MED-EL and Meludia – launched a one-of-a-kind online training tool after joining forces. With Meludia, users around the world* will be guided through over 600 interactive exercises to help refine the listening and music skills of people who use hearing devices such as cochlear implants. Users can enjoy the musical wonders of Meludia without incurring any costs, as the platform remains free, highlighting the two company’s commitment to accessibility. The Meludia experience has also expanded its geographical reach to Canada in December 2023, with Russian and Turkish language support added in 2024.
Empowering cochlear implant users through music
Johanna Boyer, Musicologist at MED-EL and cochlear implant user, expresses enthusiasm about Meludia's impact and the ongoing cooperation: "Music holds a particularly high significance at MED-EL, and Meludia is a gateway for hearing implant users to rediscover the magic of music. The extension ensures users globally can continue their independent musical exploration." Johanna also stresses that engaging in musical brain-training offers individuals with hearing loss a myriad of benefits that extend beyond the joy of music appreciation. “Studies show that by using music training tools like Meludia you can build your overall listening skills. It can help improve your listening attention, understanding of speech, and verbal memory.”
These advantages include heightened listening skills and the ability to distinguish between various sounds simultaneously, a crucial skill for comprehending conversations in noisy environments. Additionally, musical brain-training contributes to, improved focus and overall auditory capabilities, as well as auditory working memory. Moreover, it helps individuals with hearing loss to develop the skill of tuning into someone's emotions by discerning voice variations.
MED-EL is offering Meludia free of charge for 12 months to everyone registered with myMED-EL.*
Those with expired Meludia subscriptions can seamlessly activate new 12-month subscriptions.
For more information and to activate Meludia, visit myMED-EL. Users who do not have a myMED-EL account, can register online for free.*
* Please note that Meludia on myMED-EL is not available in the USA and Japan due to local laws and restrictions.
About Meludia
Meludia is a French developer of cognitive training applications based on music. Founded in 2012, Meludia won a gold medal and the grand prize at the 2014 Lépine International Competition for its groundbreaking approach to musical education, which has since been endorsed by teachers, professional musicians, and major institutions such as the prestigious Curtis Institute of Music in Philadelphia. The "Meludia Method," developed by the composer Vincent Chaintrier, is based on 25 years of research and draws from the latest advances in cognitive science, including implicit and reinforcement learning. Meludia is made unique by its innovative method which has been transformed into a fun online tool that helps users enhance their understanding and appreciation of the musical language one step at a time, all the while increasing their level of dedication, motivation, and pleasure with regard to music. www.meludia.com
About MED-EL
MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 2,700 employees from around 80 nations and 30 locations worldwide.
The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 136 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices. www.medel.com
CEO
Doz. DI Dr DDr med. h.c. Ingeborg Hochmair
Press Contact
PR & Corporate Communications
MED-EL Medical Electronics
Fürstenweg 77a
6020 Innsbruck
Austria
T: +43 5 7788
E: [email protected]
